These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22490318)

  • 1. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.
    Mehta A; Norton P; Liang H; Comunale MA; Wang M; Rodemich-Betesh L; Koszycki A; Noda K; Miyoshi E; Block T
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):925-33. PubMed ID: 22490318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
    West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS
    J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
    Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
    Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
    Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
    PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
    Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
    Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
    Naitoh A; Aoyagi Y; Asakura H
    J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
    Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
    Mita Y; Aoyagi Y; Suda T; Asakura H
    J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies.
    Liang J; Zhu J; Wang M; Singal AG; Odewole M; Kagan S; Renteria V; Liu S; Parikh ND; Lubman DM
    Sci Rep; 2019 Aug; 9(1):11580. PubMed ID: 31399619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
    Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
    J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.
    Comunale MA; Wang M; Hafner J; Krakover J; Rodemich L; Kopenhaver B; Long RE; Junaidi O; Bisceglie AM; Block TM; Mehta AS
    J Proteome Res; 2009 Feb; 8(2):595-602. PubMed ID: 19099421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
    Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
    Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation.
    Higai K; Aoki Y; Azuma Y; Matsumoto K
    Biochim Biophys Acta; 2005 Aug; 1725(1):128-35. PubMed ID: 15863355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.
    Tanabe K; Deguchi A; Higashi M; Usuki H; Suzuki Y; Uchimura Y; Kuriyama S; Ikenaka K
    Biochem Biophys Res Commun; 2008 Sep; 374(2):219-25. PubMed ID: 18619944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.